DermTech Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2017
Net Income	-89.63	-100.89	-116.68	-78.34	-36.48	-20.13	Upgrade
Depreciation & Amortization	5.58	5.85	4.46	2.3	0.49	0.09	Upgrade
Share-Based Compensation	16.53	18.57	18.93	13.28	4.97	1.3	Upgrade
Other Operating Activities	-4.55	-0.5	-1.97	0.66	2.34	0.95	Upgrade
Operating Cash Flow	-72.07	-76.98	-95.26	-62.11	-28.68	-17.79	Upgrade
Capital Expenditures	-0.15	-0.9	-3.31	-2.72	-1.83	-0.21	Upgrade
Change in Investments	46.04	30.77	-1.01	-9.79	-39.51	0	Upgrade
Investing Cash Flow	45.89	29.86	-4.32	-12.51	-41.34	-0.21	Upgrade
Share Issuance / Repurchase	5.38	6.19	1.05	230.45	44.31	20.74	Upgrade
Debt Issued / Paid	-0.1	-0.11	-0.14	-0.17	-0.01	2.08	Upgrade
Other Financing Activities	-	-	-	-	34.6	5.8	Upgrade
Financing Cash Flow	5.29	6.08	0.92	230.28	78.9	28.62	Upgrade
Net Cash Flow	-20.89	-41.04	-98.66	155.66	8.87	10.62	Upgrade
Free Cash Flow	-72.22	-77.88	-98.57	-64.83	-30.52	-18	Upgrade
Free Cash Flow Margin	-461.03%	-509.16%	-678.92%	-547.61%	-518.57%	-535.11%	Upgrade
Free Cash Flow Per Share	-2.08	-2.39	-3.28	-2.24	-1.80	-2.57	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).